(Q37206142)

18 August 2017

1 reference

title

PROCLEIX West Nile virus assay based on transcription-mediated amplification (English)

1 reference

18 August 2017

0 references

Rainer Ziermann

1

1 reference

18 August 2017

Sergio Arturo Sánchez-Guerrero

series ordinal

2

1 reference

18 August 2017

publication date

1 May 2008

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

18 August 2017

published in

1 reference

18 August 2017

volume

8

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

239-245

1 reference

The outbreak of West Nile virus infection in the New York City area in 1999

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.239

The continuing spread of West Nile virus in the western hemisphere

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.239

Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.239

West Nile virus: epidemiology, clinical presentation, diagnosis, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.239

Recent advances in the molecular biology of west nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.239

Detection of West Nile virus in the Mexican blood supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.239

West Nile virus: round five

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.239

CCR5 deficiency increases risk of symptomatic West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.239

Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.239

Insights on donor screening for West Nile virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.239

Performance evaluation of the PROCLEIX West Nile virus assay on semi-automated and automated systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.239

Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.239

Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.239

West Nile virus among blood donors in the United States, 2003 and 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.239

First international diagnostic accuracy study for the serological detection of West Nile virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.239

Immunoassay Targeting Nonstructural Protein 5 To Differentiate West Nile Virus Infection from Dengue and St. Louis Encephalitis Virus Infections and from Flavivirus Vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.239

Collaborative study to evaluate a working reagent for West Nile virus RNA detection by nucleic acid testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.239

West Nile virus: recent trends in diagnosis and vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.8.3.239

21 January 2018

Identifiers

DOI

10.1586/14737159.8.3.239

1 reference

18 August 2017

1 reference